DNX CORP has a total of 18 patent applications. Its first patent ever was published in 1992. It filed its patents most often in Canada, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, pharmaceuticals and agriculture are BEIJING JIFULIN BIOTECHNOLOGY CO LTD, DELTAGEN INC and ALLEN KEITH D.
# | Country | Total Patents | |
---|---|---|---|
#1 | Canada | 4 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | WIPO (World Intellectual Property Organization) | 4 | |
#4 | Australia | 3 | |
#5 | Finland | 1 | |
#6 | Norway | 1 | |
#7 | New Zealand | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Agriculture |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Animal care | |
#3 | Microorganisms | |
#4 | Medical preparations | |
#5 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Sharma Ajay | 11 |
#2 | Kumar Ramesh | 11 |
#3 | Swanson Mark E | 10 |
#4 | Pilder Stephen H | 10 |
#5 | Pinkert Carl A | 10 |
#6 | Logan John S | 9 |
#7 | Parsons Cynthia T | 7 |
#8 | White Steven P | 7 |
#9 | Holtzman Steven H | 7 |
#10 | Keller Hilary | 7 |
Publication | Filing date | Title |
---|---|---|
CA2170234A1 | Production of human hemoglobin in transgenic pigs | |
AU5099393A | Tetracycline repressor-mediated binary regulation system for control of gene expression in transgenic animals | |
CA2137911A1 | Production of human hemoglobin in transgenic pigs | |
CA2111348A1 | Production of human hemoglobin in transgenic pigs |